Showing results (1251-1260 of 1,302) with videos related to

Sort By:
Pageof 131
Seminars in Cancer Biology|April 21, 2015
Sustained proliferation in cancer: Mechanisms and novel therapeutic targetsMark A Feitelson, Alla Arzumanyan, Rob J Kulathinal, et al.
Hepatology (Baltimore, Md.)|November 22, 2020
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental CholangiocarcinomaLeticia Colyn, Marina Bárcena-Varela, Gloria Álvarez-Sola, et al.
Vaccine|May 16, 2022
Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in VietnamAnh Duc Dang, Thiem Dinh Vu, Ha Hai Vu, et al.
The Journal of Small Animal Practice|November 18, 2021
Serum anti-GM2 and anti-GalNAc-GD1a IgG antibodies are biomarkers for acute canine polyradiculoneuritisS K Halstead, D S Gourlay, J Penderis, et al.
Journal of Hepatology|September 23, 2021
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial functionNatália da Silva Lima, Marcos F Fondevila, Eva Nóvoa, et al.
Atherosclerosis|October 1, 2008
Association of lipoprotein lipase D9N polymorphism with myocardial infarction in type 2 diabetes: the genetics, outcomes, and lipids in type 2 diabetes (GOLD) studyMaria C Izar, Tatiana Helfenstein, Silvia S Ihara, et al.
Research Square|September 16, 2020
Patient-Reported Health Outcomes After Treatment of COVID-19 with Nebulized and/or Intravenous Neutral Electrolyzed Saline Combined with Usual Medical Care Versus Usual Medical care alone: A Randomized, Open-Label, Controlled TrialIvan Delgado-Enciso, Juan Paz-Garcia, Carlos E Barajas-Saucedo, et al.
Experimental and Therapeutic Medicine|July 26, 2021
Safety and efficacy of a COVID-19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open-label, controlled trialIvan Delgado-Enciso, Juan Paz-Garcia, Carlos E Barajas-Saucedo, et al.
Nature|June 29, 2017
mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancerAmaia Zabala-Letona, Amaia Arruabarrena-Aristorena, Natalia Martín-Martín, et al.
PLOS Global Public Health|April 9, 2025
Fighting tuberculosis hand in hand: A call to engage communities affected by TB as essential partners in researchN Venkatesan, L Faust, R Lobo, et al.
Pageof 131